Carcinoma, Bronchogenic  >>  ganitumab (AMG 479)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ganitumab (AMG 479) / Takeda, ImmunityBio
NCT00807612: QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

Terminated
1b/2
49
US
AMG 479, Carboplatin, Paclitaxel
NantCell, Inc.
Advanced Squamous Non-Small Cell Lung Cancer
08/10
08/10
NCT00819169 / 2008-005074-12: QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors

Terminated
1b/2
89
US, Europe
AMG 479, AMG 655, AMG 655 is also known as conatumumab.
NantCell, Inc.
Colorectal Cancer, Locally Advanced, Metastatic Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Sarcoma, Solid Tumors
10/10
10/11
QUILT-2.013, NCT00791154 / 2008-003292-42: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer

Completed
1b/2
204
US, Europe, RoW
AMG 479, Etoposide, Placebo, AMG 102, Carboplatin, Cisplatin
NantCell, Inc.
Lung Cancer, Small Cell Lung Cancer, Solid Tumors, Extensive-stage Small Cell Lung Cancer
06/12
02/13

Download Options